Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 4, 2011, Pages

  Sasaoka, Tetsumasa ^a   Ito, Masayuki ^a   Yamashita, Junji ^a   Nakajima, Kenji ^a   Tanaka, Issei ^a   Narita, Masakuni ^a   Hara, Yukio ^a   Hada, Kaori ^a   Takahashi, Munehisa ^a   Ohno, Youichi ^a   Matsuo, Takato ^a   Kaneshiro, Yoshiaki ^a   Tanaka, Hitoshi ^a   Kaneko, Kenji ^a  

^a Nihon Pharmaceutical Co Ltd   (Japan)

Author keywords

Inflammation; Inflammatory bowel disease; Interleukin 27; Th17 cells; Therapy

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 27; PROTEIN P28; PROTEIN SUBUNIT; SULFONIC ACID DERIVATIVE; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENTERITIS; GASTROINTESTINAL DISEASE; HELPER CELL; HISTOPATHOLOGY; IMMUNE SYSTEM; INFLAMMATION; INTESTINE ULCER; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; COLITIS; COLON; HUMANS; INTERLEUKIN-17; INTESTINAL MUCOSA; MALE; MICE; TH17 CELLS;

EID: 79955064497     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00329.2010     Document Type: Article

References (47)

1. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X. Distinct cytokine patterns identified from multiplex profile of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 15: 341-352, 2009.
2. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE. Th17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718, 2007.
3. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995-1004, 1999.
4. Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K. ATP drives kamina propria Th17 cell differentiation. Nature 455: 808-812, 2008.
5. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner 2007 HL. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8: 1380-1389, 2007.
6. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929-936, 2006.
7. Bosani M, Ardizzone S, Porro GB. Biologic targeting in the treatment of inflammatory bowel diseases. Biologics 3: 77-97, 2009.
8. Brown ME, Renner G, Field RP, Hassell T. Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system. Cytotechnology 9: 231-236, 1992.
9. Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, Grewal IS, de Sauvage FJ. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407: 916-920, 2000.
10. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. The inhibitory cytokine IL-35 contributes to regulatory T cell function. Nature 450: 566-569, 2007.
11. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463, 2006.
12. El-behi M, Ciric B, Yu S, Zhang GX, Fitzgerald DC, Rostami A. Differential effect of IL-27 on developing versus committed Th17 cells. J Immunol 183: 4957-4967, 2009.
13. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
14. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A. Suppressive effect of IL-27 on Encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179: 3268-3275, 2007.
15. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8: 1372-1379, 2007.
16. Ghilardi N, Ouyang W. Targeting the development and effector function of TH17 cells. Semin Immunol 19: 383-393, 2007.
17. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE, Bagby GJ, Nelson S, Kollis JK. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202: 761-769, 2005.
18. + effector T cells develop via a lineage distinct from the T helper type 1 and type 2 lineages. Nat Immunol 6: 1123-1132, 2005.
19. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. Interleukin-23 derives innate and T cell-mediated intestinal inflammation. J Exp Med 203: 2473-2483, 2006.
20. Ito R, Shin-Ya M, Kishida T, Urano A, Takeda R, Sakagami J, Imanishi J, Kita M, Ueda Y, Iwakura Y, Kataoka K, Okanoue T, Mazda O. Interferon-γ is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 146: 330-338, 2006.
21. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25: 221-242, 2007.
22. + T cell responses after vaccination and during Mycrobacterium tuberculosis challenge. Nat Immunol 8: 369-377, 2007.
23. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 21: 467-476, 2004.
24. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
25. Leon AJ, Gomez E, Garrote LA, Bernardo D, Barrera A, Marcos JL, Fernandez-Salazar L, Velayos B, Blanco-Quiros A, Arranz E. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patient with IBD. Mediators Inflamm 2009: 580450, 2009.
26. Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, Hahm KB, Choi SC, Yun KJ, Chung HT, Chae SC. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean populations. J Gastroenterol Hepatol 24: 1692-1696, 2009.
27. + T cells through Stat1-dependent and-independent mechanisms. Proc Natl Acad Sci USA 100: 15047-15052, 2003.
28. Matsumoto S, Okabe Y, Setoyama H, Takayama K, Ohtsuka J, Funabashi H, Imaoka A, Okada Y, Umesaki Y. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43: 71-78, 1998.
29. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 274-282, 1993.
30. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, Liew FY. Interleukin-27 attenuates collagen-induced arthritis. Ann Rheum Dis 67: 1474-1479, 2008.
31. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Hood L, Zhu Z, Tian Q, Dong C. Adistinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141, 2005.
32. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal Malefyt R, Kastelein RA. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172: 2225-2231, 2004.
33. + T cells. Immunity 16: 779-790, 2002.
34. Podolsky DK. Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
35. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286, 2007.
36. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O'shea JJ, Hennighausen L, Ernst M, Hunter CA. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945, 2006.
37. Stumhofer JS, Silver J, Hunter CA. Negative regulation of Th17 responses. Semin Immunol 19: 394-399, 2007.
38. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'shea JJ, Hunter CA. Interleukin 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8: 1363-1371, 2007.
39. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170: 4886-4890, 2003.
40. + effector T cell pool and limits intestinal inflammation in a murine model of colitis. J Immunol 183: 2037-2044, 2009.
41. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene systhesis accelerates healing in a rat model of colitis. Am J Physiol Gastrointest Liver Physiol 258: G527-G534, 1990.
42. Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59: 1073-1083, 2007.
43. Xavier RJ, Podolsky DK. Unraveling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434, 2007.
44. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-1316, 2006.
45. Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, Mu S, Xia M, Wakeham AC, Nishina H, Potter J, Saris CJ, Mak TW. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection Immunity 15: 569-578, 2001.
46. Yoshida H, Nakaya M, Miyazaki Y. Interleukin-27: a double-edged sword for offense and defense. J Leukoc Biol 86: 1295-1303, 2009.
47. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kollis JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 12: 382-388, 2006.